Bioventures Cayman Ltd Hbm is 10% at MICRUS ENDOVASCULAR CORP (MEND). They have made 26 open-market trades across 3 companies since 2007, most recently 2013-03-19.
CIK 0001232258
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
12 open-market purchases totalling $7.3M since 2008, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PCRX | SELL · 10b5-1 | 2013-03-11 | 2013-03-21 | $28.01 | $25.5M | -18.1% | +0.8% | +0.8% |
| PCRX | BUY | 2011-11-21 | 2011-11-22 | $6.50 | $2.0M | -18.1% | +0.8% | +0.8% |
| PCRX | BUY | 2011-02-08 | 2011-02-10 | $7.00 | $1.9M | -18.1% | +0.8% | +0.8% |
| MEND | SELL | 2010-03-02 | 2010-03-04 | $21.10 | $1.4M | N/A | N/A | N/A |
| MEND | SELL | 2010-02-23 | 2010-02-25 | $19.99 | $1.4M | N/A | N/A | N/A |
| MEND | SELL | 2010-02-19 | 2010-02-23 | $20.55 | $1.4M | N/A | N/A | N/A |
| MEND | SELL | 2009-08-13 | 2009-08-17 | $11.01 | $275K | N/A | N/A | N/A |
| MEND | SELL | 2009-08-12 | 2009-08-13 | $11.03 | $552K | N/A | N/A | N/A |
| MEND | SELL | 2009-08-10 | 2009-08-12 | $10.93 | $502K | N/A | N/A | N/A |
| MEND | SELL | 2009-08-10 | 2009-08-12 | $11.03 | $226K | N/A | N/A | N/A |
| MEND | SELL | 2009-08-07 | 2009-08-11 | $10.95 | $274K | N/A | N/A | N/A |
| MEND | BUY | 2008-06-20 | 2008-06-23 | $13.76 | $244K | N/A | N/A | N/A |
| MEND | BUY | 2008-06-19 | 2008-06-20 | $13.59 | $47K | N/A | N/A | N/A |
| MEND | BUY | 2008-06-17 | 2008-06-19 | $13.58 | $52K | N/A | N/A | N/A |
| MEND | BUY | 2008-06-05 | 2008-06-10 | $12.12 | $545K | N/A | N/A | N/A |
| MEND | BUY | 2008-02-15 | 2008-02-19 | $13.98 | $108K | N/A | N/A | N/A |
| MEND | BUY | 2008-02-14 | 2008-02-14 | $14.30 | $326K | N/A | N/A | N/A |
| MEND | BUY | 2008-02-13 | 2008-02-14 | $14.19 | $366K | N/A | N/A | N/A |
| MEND | BUY | 2008-02-13 | 2008-02-14 | $14.56 | $729K | N/A | N/A | N/A |
| MEND | BUY | 2008-02-12 | 2008-02-14 | $14.61 | $437K | N/A | N/A | N/A |
| MEND | BUY | 2008-02-12 | 2008-02-14 | $14.74 | $593K | N/A | N/A | N/A |
| MEND | SELL | 2007-08-22 | 2007-08-24 | $23.28 | $26K | N/A | N/A | N/A |
| MEND | SELL | 2007-08-21 | 2007-08-21 | $23.28 | $38K | N/A | N/A | N/A |
| [MEND] | SELL | 2007-08-20 | 2007-08-21 | $23.21 | $253K | N/A | N/A | N/A |
| MEND | SELL | 2007-08-17 | 2007-08-21 | $23.36 | $206K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.